Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Acta Chirurgica Latviensis

The Journal of Riga Stradins University; Latvian Association of Surgeons; Latvian Association of Paediatric Surgeons

2 Issues per year

Open Access
Online
ISSN
2199-5737
See all formats and pricing
More options …

Expression of Gene Runx2, Wnt and OPG in Palate Cleft Reconstruction Material

Emils Smitins / Dace Danberga / Mara Pilmane / Ilze Akota
Published Online: 2018-09-25 | DOI: https://doi.org/10.1515/chilat-2017-0015

Abstract

Introduction. Facial morphogenesis occurs from the fourth to the twelfth gestation week, when the cells from nerve crest migrate to the region of face, forming the primary palate. The cleft palate is an abnormality in embryogenesis period, which is characterized by the absence of fusion of palatal shelves. The incidence of cleft lip and palate is one in 700 live births. In recent years the effect of different genes and signaling molecules, including Runx2, Wnt3 and OPG have been studied in the development of cleft palate, because these substances are considered to be regulators of pathogenesis responsible for formation of bone and cartilage tissue and particularly the bone. Aim of the Study. The aim of the work was to evaluate the expression of Runx2, Wnt3 and OPG in palate bone and nasal cartilage for children with cleft palate. Material and methods.Eleven bone and cartilage samples were obtained from 21 children of the lip, soft and hard palate correction surgery. All the patients were diagnosed with clefts of the lip, alveolar process of maxilla, and palate. In the tissue sections using the immunohistochemistry method (IMH), were determined Runx2 (code: AB192256, 1: 250, Abcam GB, rabbit), Wnt3 (code: AB1992, 1: 800, Abcam GB, rabbit), and OPG (code: A0611, 1: 100, The Orbit USA, rabbit) local expression. We used a semi-quantitative census method for quantifying the positive structures. Results. Runx2 expression was observed in five patient bone tissue samples and six patient cartilage tissue samples. Of the Runx2 positive bone tissue, in one case we observed occasional, in two cases- few, in one case- moderate to numerous and in one case numerous positive osteocytes while in tissue of cartilage in two cases we observed few, in one case- few to moderate, in two casesmoderate, and in one case numerous positive chondrocytes. A significant difference in Wnt3 expiation was observed between bone and cartilage tissues. Wnt3 expressing chondrocytes were observed in all samples, where in one case- occasional, in three cases few, in one case-moderate, and in six cases-numerous positive cartilage cells were observed. The expression of the gene in the bone was observed in nine cases, which contained mostly occasional or few positive structures, except in three cases where in one Wnt3 was marked by few to moderate and in two cases numerous positive osteocytes. OPG expression was observed in all samples, but in the cartilage, the expression was more pronounced. In the cartilage in seven cases, there were numerous positive chondrocytes, in one case- few to moderate, in two cases moderate to numerous and in one case few to moderate number of chondrocytes. OPG showed variable expression. In four cases, we observed occasional to few, in one case few to moderate, in one case- moderate, in one case moderate to numerous and in four cases numerous positive bone cells. Conclusion. Cartilage tissue expresses significantly more Runx2, Wnt3 genes and OPG proteins, indicating a greater compensatory tissue capacity. In the case of palate clefts, the high expression of Wnt3 and OPG and lower expression of Runx2 could indicate a significant tissue proliferation which predominates over mineralization and ossification processes.

Keywords: cleft; cleft palate; osteocytes; chondrocytes; Runx2; Wnt3; OPG

References

  • 1. Burg M. L, Chai Y., Yao C. A., et al. Epidemiology, Etiology, and Treatment of Isolated Cleft Palate // Frontiers in Physiology, 2016; 7: 67Google Scholar

  • 2. Chenard K. E., Teven C. M., He T. C., et al. Bone Morphogenetic Proteins in Craniofacial Surgery: Current Techniques, Clinical Experiences, and the Future of Personalized Stem Cell Therapy // Journal of Biomedicine and Biotechnology, 2012; 14: 601549Google Scholar

  • 3. Cohen M. M. Jr., Perspectives on RUNX genes: An update // American Journal of Clinical Genetics, 2009; 149A (12): 2629-46Google Scholar

  • 4. Durst K. L., Heibert S. W. Role of RUNX family members in transcriptional repression and gene silencing // Nature, 2004; 23: 4220-4224Google Scholar

  • 5. Gaur T., Lengner C. J., Hovhannisyan H., et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression // The Journal of Biological Chemistry, 2005; 39: 33132-40Google Scholar

  • 6. Huang W., Yang S., Shao J., et al. Signaling and transcriptional regulation in osteoblast commitment and differentiation // Frontiers in Bioscience, 2007; 12: 3068-3092Google Scholar

  • 7. Hwang S. G., Yu S. S., Lee S. W., et al. Wnt-3a regulates chondrocyte differentiation via c-Jun/ AP-1 pathway // FEBS Letters, 2005; 579 (21): 4837-42Google Scholar

  • 8. Komori T. Regulation of osteoblast differentiation by Runx2 // Advances in Experimental Medicine and Biology, 2010; 658: 43-9Google Scholar

  • 9. Krishnan V., Bryant H.U., Macdougald O.A. Regulation of bone mass by Wnt signaling // The Journal of Clinical Investigation, 2006;116 (5) :1202-9Google Scholar

  • 10. Kusumi A., Sakaki H., Kusumi T., et al. Regulation of synthesis of osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand in normal human osteoblasts via the p38 mitogen-activated protein kinase pathway by the application of cyclic tensile strain // Journal of Bone and Mineral Metabolism, 2005; 23 (5): 373-81Google Scholar

  • 11. Kwan T. S., Pelletier J. P., Lajeunesse D., et al. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells // Clinical and Experimental Rheumatology Journal, 2008; 26 (2): 295-304Google Scholar

  • 12. L. Smane, M. Pilmane. Osteopontin, osteocalcin, and osteoprotegerin expression in human tissue affected by cleft lip and palate // SHS Web of Conferences, 2016; 30: 00008Google Scholar

  • 13. Li J., Dong S. The Signaling Pathways Involved in Chondrocyte Differentiation and Hypertrophic Differentiation // Stem Cells International, 2016; 12: 2470351Google Scholar

  • 14. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease // Annual Review of Cell and Developmental Biology, 2004; 20: 781-810Google Scholar

  • 15. Menezes R., Letra A., Kim A. H., et al. Studies with Wnt genes and nonsyndromic cleft lip and palate // Birth Defects Research. Part A, Clinical and Molecular Teratology Journal, 2010; 88 (11): 995-1000Google Scholar

  • 16. Murthy J., Bhaskar L. V. K. S. Current concepts in genetics of nonsyndromic clefts // Indian Journal of Plastic Surgery, 2009; 42 (1): 68-81Google Scholar

  • 17. Panamonta V., Pradubwong S., Panamonta M., et al. Global Birth Prevalence of Orofacial Clefts: A Systematic Review // Journal of the Medical Association of Thailand, 2015; 98 (7): S11-21Google Scholar

  • 18. Stricker S., Fundele R., Vortkamp A, et. al. Role of Runx Genes in Chondrocyte Differentiation // Developmental Biology, 2002; 245, 95-108Google Scholar

  • 19. Tetsunaga T., Nishida K., Furumatsu T., et., al. Regulation of mechanical stress-induced MMP- 13 and ADAMTS-5 expression by RUNX-2 transcriptional factor in SW1353 chondrocyte-like cells // Osteoarthritis and Cartilage, 2011; 19 (2): 222-32Google Scholar

  • 20. Udagawa N., Takahashi N., Yasuda H., et al. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function // Journal of Endocrinology, 2000; 141 (9): 3478-84Google Scholar

  • 21. Yu W., Serrano M., Miguel S. S, et al. Cleft lip and palate genetics and application in early embryological development // Indian Journal of Plastic Surgery, 2009; 42: S35-S50Google Scholar

  • 22. Zhang X., Liu Y., Wang X., et.al. Analysis of novel RUNX2 mutations in Chinese patients with cleidocranial dysplasia // PLOS One, 2017; 12 (7): e0181653.Google Scholar

About the article

Published Online: 2018-09-25

Published in Print: 2017-12-20


Citation Information: Acta Chirurgica Latviensis, Volume 17, Issue 2, Pages 3–8, ISSN (Online) 2199-5737, DOI: https://doi.org/10.1515/chilat-2017-0015.

Export Citation

© 2018 Emils Smitins, published by Sciendo. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License. BY-NC-ND 4.0

Comments (0)

Please log in or register to comment.
Log in